Suling Huang

1.2k total citations
32 papers, 630 citations indexed

About

Suling Huang is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Suling Huang has authored 32 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Epidemiology. Recurrent topics in Suling Huang's work include Metabolism, Diabetes, and Cancer (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Adipose Tissue and Metabolism (5 papers). Suling Huang is often cited by papers focused on Metabolism, Diabetes, and Cancer (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Adipose Tissue and Metabolism (5 papers). Suling Huang collaborates with scholars based in China, Sweden and United States. Suling Huang's co-authors include Ying Leng, Ying Feng, Yu Shen, Mengmeng Ning, Ying Leng, Zhuohui Zhao, Song Zhang, Jianhua Shen, Yangliang Ye and Jing‐Xu Gong and has published in prestigious journals such as Journal of the American Chemical Society, International Journal of Molecular Sciences and Diabetologia.

In The Last Decade

Suling Huang

28 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suling Huang China 13 333 155 131 103 90 32 630
Lei Lei China 16 348 1.0× 118 0.8× 117 0.9× 107 1.0× 89 1.0× 49 671
Marı́a Cristina Carrillo Argentina 16 271 0.8× 132 0.9× 79 0.6× 113 1.1× 74 0.8× 37 712
Mi Ae Kang South Korea 12 331 1.0× 74 0.5× 186 1.4× 57 0.6× 78 0.9× 22 810
Jingda Li China 12 286 0.9× 222 1.4× 109 0.8× 55 0.5× 65 0.7× 27 688
Donatella Vizza Italy 17 450 1.4× 151 1.0× 73 0.6× 80 0.8× 77 0.9× 31 947
Tian Zhang China 16 391 1.2× 233 1.5× 46 0.4× 61 0.6× 132 1.5× 40 826
Shimaa M. Elshazly Egypt 15 167 0.5× 101 0.7× 91 0.7× 70 0.7× 89 1.0× 36 567
Dongyan Gao China 15 368 1.1× 212 1.4× 67 0.5× 57 0.6× 72 0.8× 21 771
Syed Anees Ahmed India 16 188 0.6× 104 0.7× 124 0.9× 48 0.5× 96 1.1× 35 591

Countries citing papers authored by Suling Huang

Since Specialization
Citations

This map shows the geographic impact of Suling Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suling Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suling Huang more than expected).

Fields of papers citing papers by Suling Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suling Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suling Huang. The network helps show where Suling Huang may publish in the future.

Co-authorship network of co-authors of Suling Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Suling Huang. A scholar is included among the top collaborators of Suling Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suling Huang. Suling Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Haoyu, Suling Huang, Jing Ren, et al.. (2025). A novel TGR5 agonist Sauchinone ameliorates IMQ induced murine psoriasis by regulating macrophage polarization. Journal of Advanced Research. 80. 627–642.
2.
3.
Huang, Suling, et al.. (2025). Design, synthesis and biological evaluation of Alisol B derivatives for potential treatment of non-alcoholic steatohepatitis. Bioorganic Chemistry. 155. 108132–108132. 2 indexed citations
4.
Wu, Xing‐De, Yanli Liu, Yu Shen, et al.. (2025). Activation of SIK1 by phanginin A regulates skeletal muscle glucose uptake by phosphorylating HADC4/5/7 and enhancing GLUT4 expression and translocation. Natural Products and Bioprospecting. 15(1). 24–24. 1 indexed citations
5.
6.
Wang, Haiyin, et al.. (2024). Clerodane diterpenoids from the vine stems of Fibraurea recisa Pierre and their hepatic gluconeogenesis inhibitory activity. Phytochemistry. 232. 114364–114364. 1 indexed citations
7.
8.
Wu, Xing‐De, et al.. (2022). Design, synthesis and structural-activity relationship studies of phanginin A derivatives for regulating SIK1-cAMP/CREB signaling to suppress hepatic gluconeogenesis. European Journal of Medicinal Chemistry. 232. 114171–114171. 9 indexed citations
9.
Chen, Lili, Suling Huang, Yangliang Ye, et al.. (2022). Phenotypic screening-based drug discovery of furan-2-carboxylic acid derivatives for the amelioration of type 2 diabetes mellitus (T2DM). European Journal of Medicinal Chemistry. 246. 114994–114994. 1 indexed citations
10.
Huang, Suling, Wei Xie, Yangliang Ye, et al.. (2022). Coronarin A modulated hepatic glycogen synthesis and gluconeogenesis via inhibiting mTORC1/S6K1 signaling and ameliorated glucose homeostasis of diabetic mice. Acta Pharmacologica Sinica. 44(3). 596–609. 5 indexed citations
11.
Ye, Yangliang, Ying Feng, Yu Shen, et al.. (2021). SL010110, a lead compound, inhibits gluconeogenesis via SIRT2-p300-mediated PEPCK1 degradation and improves glucose homeostasis in diabetic mice. Acta Pharmacologica Sinica. 42(11). 1834–1846. 13 indexed citations
12.
Liu, Siwen, Suling Huang, Xing‐De Wu, et al.. (2020). Activation of SIK1 by phanginin A inhibits hepatic gluconeogenesis by increasing PDE4 activity and suppressing the cAMP signaling pathway. Molecular Metabolism. 41. 101045–101045. 25 indexed citations
13.
Huang, Suling, Mengmeng Ning, Yangliang Ye, et al.. (2019). TGR5 agonist ameliorates insulin resistance in skeletal muscles and improves glucose homeostasis in diabetic mice. Metabolism. 99. 45–56. 52 indexed citations
14.
Xie, Wei, Yangliang Ye, Ying Feng, et al.. (2018). Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP/PKA/CREB Pathway Through Indirect Activation of PDE 3 via ERK/STAT3. Frontiers in Pharmacology. 9. 476–476. 22 indexed citations
15.
Huang, Shujuan, Suling Huang, Xi Wang, et al.. (2016). Downregulation of lipin-1 induces insulin resistance by increasing intracellular ceramide accumulation in C2C12 myotubes. International Journal of Biological Sciences. 13(1). 1–12. 21 indexed citations
16.
Huang, Suling, et al.. (2015). AICAR and Metformin Exert AMPK-dependent Effects on INS-1E Pancreatic β-cell Apoptosis via Differential Downstream Mechanisms. International Journal of Biological Sciences. 11(11). 1272–1280. 26 indexed citations
17.
Zeng, Hongliang, Suling Huang, Fuchun Xie, et al.. (2015). Yhhu981, a novel compound, stimulates fatty acid oxidation via the activation of AMPK and ameliorates lipid metabolism disorder in ob/ob mice. Acta Pharmacologica Sinica. 36(3). 343–352. 11 indexed citations
18.
Huang, Suling, et al.. (2012). Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice. Acta Pharmacologica Sinica. 33(9). 1195–1203. 39 indexed citations
19.
Huang, Suling, Ruth T. Yu, Jing‐Xu Gong, et al.. (2011). Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia. 55(5). 1469–1481. 89 indexed citations
20.
Feng, Ying, et al.. (2010). Emodin, a natural product, selectively inhibits 11β‐hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet‐induced obese mice. British Journal of Pharmacology. 161(1). 113–126. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lei Lei Breakdown of academic impact, for papers by Marı́a Cristina Carrillo Breakdown of academic impact, for papers by Mi Ae Kang Breakdown of academic impact, for papers by Jingda Li Breakdown of academic impact, for papers by Donatella Vizza Breakdown of academic impact, for papers by Tian Zhang Breakdown of academic impact, for papers by Shimaa M. Elshazly Breakdown of academic impact, for papers by Dongyan Gao Breakdown of academic impact, for papers by Syed Anees Ahmed
Rankless by CCL
2026